1. Home
  2. MYSZ vs RDHL Comparison

MYSZ vs RDHL Comparison

Compare MYSZ & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYSZ
  • RDHL
  • Stock Information
  • Founded
  • MYSZ 1999
  • RDHL 2009
  • Country
  • MYSZ Israel
  • RDHL Israel
  • Employees
  • MYSZ N/A
  • RDHL N/A
  • Industry
  • MYSZ Computer Software: Prepackaged Software
  • RDHL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYSZ Technology
  • RDHL Health Care
  • Exchange
  • MYSZ Nasdaq
  • RDHL Nasdaq
  • Market Cap
  • MYSZ 8.2M
  • RDHL 8.2M
  • IPO Year
  • MYSZ N/A
  • RDHL N/A
  • Fundamental
  • Price
  • MYSZ $1.84
  • RDHL $5.85
  • Analyst Decision
  • MYSZ Strong Buy
  • RDHL
  • Analyst Count
  • MYSZ 1
  • RDHL 0
  • Target Price
  • MYSZ $3.00
  • RDHL N/A
  • AVG Volume (30 Days)
  • MYSZ 228.7K
  • RDHL 11.1K
  • Earning Date
  • MYSZ 03-31-2025
  • RDHL 04-07-2025
  • Dividend Yield
  • MYSZ N/A
  • RDHL N/A
  • EPS Growth
  • MYSZ N/A
  • RDHL N/A
  • EPS
  • MYSZ N/A
  • RDHL N/A
  • Revenue
  • MYSZ $9,632,000.00
  • RDHL $3,707,000.00
  • Revenue This Year
  • MYSZ $35.62
  • RDHL $224.90
  • Revenue Next Year
  • MYSZ $12.88
  • RDHL $82.69
  • P/E Ratio
  • MYSZ N/A
  • RDHL N/A
  • Revenue Growth
  • MYSZ 43.89
  • RDHL N/A
  • 52 Week Low
  • MYSZ $0.36
  • RDHL $5.41
  • 52 Week High
  • MYSZ $9.40
  • RDHL $20.28
  • Technical
  • Relative Strength Index (RSI)
  • MYSZ 43.13
  • RDHL 40.41
  • Support Level
  • MYSZ $1.86
  • RDHL $5.80
  • Resistance Level
  • MYSZ $2.30
  • RDHL $6.26
  • Average True Range (ATR)
  • MYSZ 0.26
  • RDHL 0.31
  • MACD
  • MYSZ -0.04
  • RDHL 0.01
  • Stochastic Oscillator
  • MYSZ 12.12
  • RDHL 19.33

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

Share on Social Networks: